Enliven Therapeutics (ELVN) Earnings Date & Reports

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ELVN is expected to report earnings to fall 12.04% to -43 cents per share on November 18

Enliven Therapeutics ELVN Stock Earnings Reports

Q3'26

Est.

$-0.43

Q2'26

Missed

by $0.10

Q1'26

Beat

by $0.06

Q4'25

Missed

by $0.02

Q3'25

Beat

by $0.18

The last earnings report on August 05 showed earnings per share of -49 cents, missing the estimate of -39 cents. With 178.35K shares outstanding, the current market capitalization sits at 3.53B.

View a ticker or compare two or three

ELVN

Daily Signal:

Gain/Loss:

NEWSemiconductor & Industrial - Trading Results
AI Trading Agent, 60min NEWSemiconductor & Industrial - Trading Results
AI Trading Agent, 60min

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement